Article
Seroprevalence, Genotyping, and Monitoring of Hepatitis C Viral Loads in Patients on Antivirals in Burkina Faso.
Intervirology - 1 Jan 2022
Yelemkoure Edwige T, Yonli Albert T, Sombie Hermann K, Tao Issoufou, Zouré Abdou Azaque, Ouattara Abdoul Karim, Sorgho Abel P, Zongo Arsène W, Zeba Moctar T A, Kiendrebeogo Isabelle T, Bado Prosper, Kabré Madeleine K, Zohoncon Théodora M, Djigma Florencia W, Obiri-Yeboah Dorcas, Simpore Jacques
Abstract excerpt
INTRODUCTION: Hepatitis C virus (HCV) infection remains a major public health problem worldwide. In Burkina Faso, nearly 720,000 people are living with HCV, and each year about 900 people die from complications of cirrhosis or hepatocellular carcinoma. This study was planned to determine the HCV seroprevalence, characterize circulating genotypes, and monitor HCV viral loads in patients under treatment with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.